Chloroquine, An Autophagy Inhibitor, Enhances The Cytotoxicity of Gefitinib in Non Small Cell Lung Cancer Cells
碩士 === 國立陽明大學 === 藥理學研究所 === 100 === Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs), including gefitinib, are effective for patients with non small cell lung cancers (NSCLCs). However, patients eventually develop drug resistance. Autophagy, one of the processes to degrading...
Main Authors: | Mei-Yi Wu, 吳玫憶 |
---|---|
Other Authors: | Anya Maan-Yuh Lin |
Format: | Others |
Language: | zh-TW |
Published: |
2012
|
Online Access: | http://ndltd.ncl.edu.tw/handle/69956317540921811835 |
Similar Items
-
Chloroquine enhances gefitinib cytotoxicity in gefitinib-resistant nonsmall cell lung cancer cells.
by: Mei-Chuan Tang, et al.
Published: (2015-01-01) -
Gefitinib in Non Small Cell Lung Cancer
by: Raffaele Costanzo, et al.
Published: (2011-01-01) -
Effects of BTK inhibitor on gefitinib-resistant non-small cell lung cancer
by: Yu-TiFang, et al.
Published: (2017) -
Gefitinib in Advanced Non-small-cell Lung Cancer
by: Zhenjun YANG, et al.
Published: (2009-05-01) -
LPIN1 Induces Gefitinib Resistance in EGFR Inhibitor-Resistant Non-Small Cell Lung Cancer Cells
by: Cho, J.H, et al.
Published: (2022)